This article is an abstract of Patrick Chiu’s forthcoming book “Transformation from Colonial Chemist to Global Health and Beauty Retailer: A S Watson” due to release at the end of May 2022. Pre-ordering at the Amazon Books is available or World Scientific with the discount code WSASOC20, valid until September 30, 2022.
Disparities & Inequalities in Ending the HIV Epidemic: Pre-exposure Prophylaxis (PrEP)
Editor’s Note: This post by Maeleigh Tidd is the second in our Pharmaceutical Inequalities series. She explores the recent Ending the HIV Epidemic Initiative in the US, with a particular focus on prevention strategies, specifically PrEP, that are being implemented to assist in ending the epidemic.
NDSAG 2022 conference 9th June, London
On the 9th June 2022 New Directions in the Study of Alcohol Group (NDSAG) returns with an in-person conference at London South Bank University.
Psychedelics in the treatment of substance use disorders: the case of ibogaine for the treatment of opioid dependence.
Editor’s Note: This post by Anny Ortiz is the first in our Pharmaceutical Inequalities series. She explores the existing research landscape of psychedelics and then draws upon her own lived experience of working in a treatment center that offered ibogaine-assisted detoxification to discuss the affordances and unanswered questions of using psychedelics in treatment.
Points Interview: Dr Reiko Kanazawa
Today’s post features an interview with Reiko Kanazawa, a postdoctoral fellow at the University of Edinburgh. She is a contemporary historian of global health, international development and drug control, with a particular focus on South Asian Studies.
Reiko recently authored ‘Governing Drugs Globally: The World Health Organization and Public Health in International Drug Control‘ within the Spring 2022 issue of the Social History of Alcohol and Drugs. Find out more about Reiko’s background, article and future research plans in this interview.
Pharmaceutical Inequalities
Lucas Richert introduces a new ‘Points’ feature for 2022: Pharmaceutical Inequalities. Contributing Authors for the series will explore 4 emerging themes within pharmaceuticals through a range of content shared on the blog.
Elizabeth Bass, The G-Woman at the Federal Bureau of Narcotics – Part 1
Editor’s Note: In the first of two posts which offer new additions to former ‘Points’ feature ‘Hidden Figures of Drug History‘ Bob Beach explores the colorful career of Elizabeth Bass prior to her role as a G-Man within the Federal Bureau of Narcotics.
Points Interview: Harry Shapiro
Today we’re excited to feature a Points Interview with Harry Shapiro, the author of ‘Fierce Chemistry: a History of UK Drug Wars’.